SCHEMBL1269586

SCHEMBL1269586

CCNS(=O)(=O)c1ccc(Sc2ccc(NS(=O)(=O)c3ccc(C(F)(F)F)cc3Cl)nc2C(=O)C2CC2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIK3C3 Q8NEB9 1/20 0.38
▸ LMNA P02545 4/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ TP53 P04637 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ ALOX15 P16050 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ PPARG P37231 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ CCKBR P32239 1/20 0.36
▸ PTGDR2 Q9Y5Y4 4/20 0.35
▸ PTGDR Q13258 3/20 0.35
▸ HCRTR1 O43613 1/20 0.34
▸ HCRTR2 O43614 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ ALDH1A1 P00352 3/20 0.34
▸ GLA P06280 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1269946 0.90 PTGDR2 (0.40) PIK3C3LMNAMAPTPPARGPTGDR2
SCHEMBL1268610 0.90 SMN1; SMN2 (0.37) PIK3C3LMNAMAPTHTTPPARG
SCHEMBL1268965 0.90 PIK3C3 (0.37) PIK3C3LMNAPPARGGAACCKBR
SCHEMBL1268968 0.89 PPARG (0.37) PIK3C3LMNAPPARGGAACCKBR
SCHEMBL1269048 0.88 PIK3C3 (0.39) PIK3C3LMNAMEN1TP53MAPT
SCHEMBL1268781 0.87 CCKBR (0.38) PIK3C3LMNAPPARGGAACCKBR
SCHEMBL1269953 0.86 CCKBR (0.42) PIK3C3LMNAMEN1MAPTKMT2A
SCHEMBL1269628 0.86 CCKBR (0.43) PIK3C3LMNAMEN1MAPK1HTT
SCHEMBL1269726 0.85 CCR6 (0.35) PIK3C3GAACCKBRMCL1SCN9A
SCHEMBL1269770 0.84 GAA (0.42) LMNAMEN1MAPTHTTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7893077-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2011-02-22 — — US disclosed
US-7893077-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2011-02-22 — — US disclosed
US-7893077-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2011-02-22 — — US disclosed
EP-1786782-B1 BISARYL-SULFONAMIDES AMGEN INC (US) 2010-03-31 — — EP disclosed
EP-1786782-B1 BISARYL-SULFONAMIDES AMGEN INC (US) 2010-03-31 — — EP disclosed
US-20090221584-A1 Bisaryl-sulfonamides AMGEN INC. 2009-09-03 — — US disclosed
US-20090221584-A1 Bisaryl-sulfonamides AMGEN INC. 2009-09-03 — — US disclosed
US-20090221584-A1 Bisaryl-sulfonamides AMGEN INC. 2009-09-03 — — US disclosed
US-7544702-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2009-06-09 — — US disclosed
US-7544702-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2009-06-09 — — US disclosed
US-7544702-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2009-06-09 — — US disclosed
US-20060084802-A1 Bisaryl-sulfonamides AMGEN INC. 2006-04-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090221584-A1 Bisaryl-sulfonamides PPARD, PPARA, PPARG PIK3C3 1316/4885LMNA 2576/4885MEN1 4841/4885
US-20060084802-A1 Bisaryl-sulfonamides PPARD, PPARA, PPARG PIK3C3 1316/4885LMNA 2576/4885MEN1 4841/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback